Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reiners

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2009
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawalR Elisei, M Schlumberger, A Driedger, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled studyF Pacini, P W Ladenson, M Schlumberger, et al.
Acta Neuropathologica|April 14, 2023
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosisMatei Bolborea, Pauline Vercruysse, Tselmen Daria, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancerB R Haugen, F Pacini, C Reiners, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2009
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawalR Elisei, M Schlumberger, A Driedger, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled studyF Pacini, P W Ladenson, M Schlumberger, et al.
Acta Neuropathologica|April 14, 2023
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosisMatei Bolborea, Pauline Vercruysse, Tselmen Daria, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancerB R Haugen, F Pacini, C Reiners, et al.
Pageof 23